ADDISON COLLINS: Open Payments
NPI 1548722242 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 38 payments from 12 companies in 2025. Trend: 2023 $1,001 · 2024 $619 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $246 |
| MERZ NORTH AMERICA, INC. | 2 | $157 |
| Novartis Pharmaceuticals Corporation | 5 | $84 |
| LEO Pharma Inc. | 3 | $78 |
| GENZYME CORPORATION | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Lilly USA, LLC | 3 | $46 |
| Genentech USA, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, ADBRY, RINVOQ, TALTZ, Xolair, AYVAKIT.
Industry payments across MT — which companies pay providers there.
